Registration

Start earning
- Start earning
- Financial instruments
- Trading platform
- Types of accounts
- Payment systems
- Margin calls
- Assets: Currency pairs
- Assets: CFD on metals
- Assets: CFD on index
- CFD on European Companies Stocks
- Assets: CFD US Stocks
- Assets: CFD on energy
- CFD on Commodities
- Assets: CFD on cryptocurrencies
- Assets: CFD on ETF
- CFD on Bonds
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Invest
- Invest
- Copy Trading
  - Copy Trading
  - Copy trading service
  - How it works
  - Rating of the best traders
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Analytics
- Analytics
- Trading Central exclusive analytics
- Market News
- Economic Calendar
- Market Reviews
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Training
- Training
- Programs
- Terminology
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Affiliate program
- Affiliate program
- Cooperation options
- Multi-level
- Fast CPA
- Introducing broker
- Flexible
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Esperio
- Esperio
- About company
- News
- Mass Media about us
- Reviews
- Legal information
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Promotions, bonuses, VIP
- Promotions, bonuses, VIP
- Extra Empower
- Double Empower
- Empower CashBack
- 2% per month - 24% per year
- Vip-service
- Trading volume requirements
- Double Deal GOLD
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned

МТ4 web login МТ5 web login

+4 202 340 766 95 Live Chat

Registration

Start earning
- Start earning
- Financial instruments
- Trading platform
- Types of accounts
- Payment systems
- Margin calls
- Assets: Currency pairs
- Assets: CFD on metals
- Assets: CFD on index
- CFD on European Companies Stocks
- Assets: CFD US Stocks
- Assets: CFD on energy
- CFD on Commodities
- Assets: CFD on cryptocurrencies
- Assets: CFD on ETF
- CFD on Bonds
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Invest
- Invest
- Copy Trading
  - Copy Trading
  - Copy trading service
  - How it works
  - Rating of the best traders
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Analytics
- Analytics
- Trading Central exclusive analytics
- Market News
- Economic Calendar
- Market Reviews
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Training
- Training
- Programs
- Terminology
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Affiliate program
- Affiliate program
- Cooperation options
- Multi-level
- Fast CPA
- Introducing broker
- Flexible
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Esperio
- Esperio
- About company
- News
- Mass Media about us
- Reviews
- Legal information
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned
Promotions, bonuses, VIP
- Promotions, bonuses, VIP
- Extra Empower
- Double Empower
- Empower CashBack
- 2% per month - 24% per year
- Vip-service
- Trading volume requirements
- Double Deal GOLD
Stay Tuned!
For Trading Central market analysis to empower your trades!
Stay Tuned

Main
Start earning
CFD US Stocks
ABBV

Financial instrument specification

AbbVie, Inc. (NYSE) ABBV

203.73 209 -0.7600(-0.37%)

Start trading

Graph ABBV

1 5 15 30 1h 4h 1d 1w 1m

209 -0.7600(-0.37%)

Contract Size, MT5	100
Minimum spread	0.21
Swap long, MT5, (%)	-0.5
Swap short, MT5, (%)	-0.5
Precision (digits)	2
Spread	0.10
Average spread	0.15306
Bid	202.58

Ask	202.68
Commission, %	0.1
Execution type:	Market execution
Hedged Margin	50,00%
Margin, MT5	20%
Swap history
Date Long swap Short swap 05.03.2025 -0.5 -0.5 04.03.2025 -0.5 -0.5 03.03.2025 -0.5 -0.5 28.02.2025 -0.5 -0.5 27.02.2025 -0.5 -0.5 26.02.2025 -0.5 -0.5 25.02.2025 -0.4 -0.4 24.02.2025 -0.4 -0.4 21.02.2025 -0.4 -0.4 20.02.2025 -0.4 -0.4 19.02.2025 -0.4 -0.4 18.02.2025 -0.4 -0.4 17.02.2025 -0.35 -0.35 14.02.2025 -0.35 -0.35 13.02.2025 -0.35 -0.35 12.02.2025 -0.35 -0.35 11.02.2025 -0.35 -0.35 10.02.2025 -0.35 -0.35 07.02.2025 -0.35 -0.35 06.02.2025 -0.35 -0.35 05.02.2025 -0.35 -0.35 04.02.2025 -0.35 -0.35
Triple swap day, MT5	Friday
Server Time	GMT+2
Trading schedule (CET)	Mon: 15:32-21:55 Tue: 15:32-21:55 Wed: 15:32-21:55 Thu: 15:32-21:55 Fri: 15:32-21:55

Instruments calculator

Select MT type*

Choose an instrument

Order type

Enter the transaction volume

Leverage

Choose deposit currency

Calculations aren't made for Cent accounts.

You will spend
of the deposit

The asset price as of is :

Quotes are given for the current trading day. The actual cost of the instrument will be shown upon purchase.

Calculator Loading

About the asset

Name	AbbVie, Inc. (NYSE)
Ticker	ABBV
Branch	AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.
Products	The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc.
Year of foundation	2011
Headquarters	North Chicago, Illinois
ISIN code	US00287Y1091

How to buy or sell AbbVie, Inc. (NYSE)

Register on the website and set up a personal account.
We recommends to top up the account for a minimum of $100 to trade.
Invest into the instrument that interests you.

Become an investor

If your trading positions are open from Wednesday to Thursday, the swap on them will be tripled. The exception is CFDs on commodities and CFDs on indexes: a triple swap on these instruments is charged on Friday. Information about swaps for your transactions is updated in the trading terminal daily at 23:55.

Short selling on some types of financial instruments may be temporarily prohibited. This is due to restrictions on the part of counterparties or regulatory authorities. Please check the information in the Support Service.